Viral infections and the development of asthma in children
- PMID: 25165549
- PMCID: PMC4040725
- DOI: 10.1177/2049936113497202
Viral infections and the development of asthma in children
Abstract
Viral aetiology, host susceptibility (in particular allergic predisposition and sensitization), and illness severity, timing and frequency all appear to contribute as synergistic factors to the risk of developing asthma. Experimental models have shown both innate and adaptive immune responses contribute to this risk with lung inflammatory cells showing marked differences in phenotype and function in young compared with older animals, and these differences are further enhanced following virus infection. Findings to date strongly suggest that the impact of infant and preschool viral infections on the maturing immune system and developing lung that subsequently result in an asthma phenotype occur during a critical susceptibility period, and in a genetically susceptible host. There are currently no therapeutic strategies that allow primary or secondary prevention of asthma following early life viral respiratory infections in high-risk children, thus a focus on understanding the mechanisms of progression from viral wheezing in infants and preschool children to asthma development are urgently needed. This review summarizes the data reporting the role of the two most common viruses, that is, respiratory syncytial virus and human rhinovirus, that result in asthma development, comparing risk factors for disease progression, and providing insight into strategies that might be adopted to prevent asthma development.
Keywords: asthma; preschool wheeze; respiratory syncytial virus; rhinovirus; virus.
References
-
- Aberle J., Aberle S., Dworzak M., Mandl C., Rebhandl W., Vollnhofer G., et al. (1999) Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 160: 1263–1268 - PubMed
-
- Akinbami L., Schoendorf K. (2002) Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 110: 315–322 - PubMed
-
- Andabaka T., Nickerson J., Rojas-Reyes M., Rueda J., Bacic V., Barsic B. (2013) Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 4: CD006602–CD006602 - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources